Clinical Trials Directory

Trials / Conditions / Myeloid Leukemia, Chronic, Chronic-Phase

Myeloid Leukemia, Chronic, Chronic-Phase

8 registered clinical trials studyying Myeloid Leukemia, Chronic, Chronic-Phase.

StatusTrialSponsorPhase
CompletedPonatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the E
NCT02467270
TakedaPhase 2
CompletedTreating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib
NCT02348957
Onco Medical Consult GmbH—
TerminatedChronic Myelod Leukemia Registry at Asan Medical Center
NCT01761695
Asan Medical Center—
CompletedComparison of Imatinib Versus Dasatinib in Patients With Newly-diagnosed Chronic Phase Chronic Myeloid Leukaem
NCT01460693
Newcastle UniversityPhase 3
WithdrawnPhase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phas
NCT00324077
Bristol-Myers SquibbPhase 1
TerminatedHomoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)
NCT00114959
ChemGenex PharmaceuticalsPhase 2
CompletedChronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
NCT00123474
Bristol-Myers SquibbPhase 3
CompletedExploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase
NCT00510926
University of BolognaPhase 2